No psychiatry without psychopharmacology.

Awakening to the psychopharmacology of sleep and arousal: novel neurotransmitters and wake-promoting drugs.

Exciting new developments in the psychopharmacology of wakefulness are clarifying the neurotransmitters, pathways, and drugs that impact this important physiologic state. Selectively inducing normal wakefulness without stimulating external vigilance may lead to therapeutic benefits not only in sleep disorders but also in cognitive disorders and conditions associated with fatigue.

What research is needed in social psychiatry?

There is no such a thing as psychiatry without a social component. If the XIXth Century has been mostly dedicated to clinical descriptions and classification, if the XXth Century has been mostly therapeutic (psychotherapies, psychopharmacology and biological psychiatry), it is highly probable that the XXIst Century will be mostly oriented towards psycho-social psychiatry and mental health. Rese...

Development of a Diverse Learning Experience for Diverse Psychiatry Resident Needs: A Four-Year Biological Psychiatry Curriculum Incorporating Principles of Neurobiology, Psychopharmacology, and Evidence-Based Practice

OBJECTIVE A clinically relevant approach to patient care grounded in neurobiological constructs and evidence based practice which emphasizes a relevant psychopharmacology is needed to optimally train psychiatry residents. METHODS We implemented a biological psychiatry course that now incorporates neurobiology, psychopharmacology, and evidence-based practice in conjunction with a Research Doma...

BEST PRACTICES IN EVALUATION AND TREATMENT OF AGITATION The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup

Does evidence from clinical trials in psychopharmacology apply in clinical practice?

The art of psychopharmacology derives from the science of psychopharmacology, but still requires wisdom, judgment, and experience to translate findings from clinical trials of a new drug into clinical practice.